March/April 2014

This article is an early utilization review of newer, more effective, and more costly regimens for the treatment of hepatitis C.

As the administration looks at improving the insurance marketplace, patient advocates are developing a wish list of modifications to ensure that it is more patient focused.

This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.

Pharmacosynchrony is the application of innovative clinical, analytic, and technologic pharmacy solutions to drive improved care coordination and higher-quality, more patient-centered care.

Successful performance of medication reconciliation can have a positive impact on patient response to a hospital stay as well as support improvement in clinical quality and financial outcome.

There are 10 steps that need to be taken to help payers more adequately address the problem of inappropriate prescribing of pain medications.